Atherosclerosis-targeted liposome nanocarrier delivery system and preparation method therefor
US-2024424132-A1 · Dec 26, 2024 · US
Method Of Treating Chronic Obstructive Pulmonary Disease (CPD) With Verproside
US2017266142A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2017266142-A1 |
| Application number | US-201615384302-A |
| Country | US |
| Kind code | A1 |
| Filing date | Dec 19, 2016 |
| Priority date | Apr 10, 2013 |
| Publication date | Sep 21, 2017 |
| Grant date | — |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A composition comprising a purified extract isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient or the compounds isolated therefrom as an active ingredient for treating a chronic obstructive pulmonary disease and the use thereof. Inventive purified extract and compounds showed potent anti-COPD activity without beta-2-receptor agonistic response through various in vivo tests as well as in vitro test. Therefore, it can be used as the therapeutics or functional health food for treating and preventing chronic obstructive pulmonary disease (COPD).
First claim
Opening claim text (preview).
1 .- 14 . (canceled) 15 . A method of treating chronic obstructive pulmonary disease (COPD) in a mammal comprising administering a therapeutically effective amount of verproside to the mammal suffering from chronic obstructive pulmonary disease (COPD). 16 . A method of treating chronic obstructive pulmonary disease (COPD) in a mammal comprising administering a composition comprising a therapeutically effective amount of verproside and a pharmaceutically acceptable carrier or excipient to the mammal suffering from chronic obstructive pulmonary disease (COPD).
Assignees
Inventors
Classifications
Drugs for disorders of the respiratory system · CPC title
Plant extracts, their artificial duplicates or their derivatives · CPC title
Scrophulariaceae (Figwort family) · CPC title
having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin {, digitoxin or digoxin} · CPC title
Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US2017266142A1 cover?
- A composition comprising a purified extract isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient or the compounds isolated therefrom as an active ingredient for treating a chronic obstructive pulmonary disease and the use thereof. Inventive purified extract and compounds showed potent anti-COPD activity without beta-2-receptor agonistic res…
- Who is the assignee on this patent?
- Yungjin Pharmaceutical Co Ltd, Korea Res Inst Bioscience & Biotechnology
- What technology area does this patent fall under?
- Primary CPC classification A61K31/192. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Thu Sep 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).